Skip to main content
. 2021 Jun 1;11:11478. doi: 10.1038/s41598-021-90748-9

Figure 6.

Figure 6

Progression-free survival of PC patients categorized by 4F2hc and SKP2 expression. Prognostic significance of 4F2hc expression for progression-free survival (PFS) (A), and prognostic significance of SKP2 expression for (PFS) (B). Prognostic significance of high 4F2hc/high SKP2 expression and low 4F2hc/low SKP2 expression, others are low 4F2hc/high SKP2 or high 4F2hc/low SKP2 (C). N.S. No significant difference. ** p < 0.01.